Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-000871-19Phase 4Completed
Phase 4, randomised, double-blind trial of chondroitin sulfate in osteoarthritis (OA) and knee osteoarthritis (OA) (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoints: Global pain score change and Lequesne Index change. Started Mar 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-000871-19.